Project Lead: Gregor Goetz
Project Team: Reinhard Jeindl, Andrea Fried; Gregor Götz
Duration: Q3 - Q4 2026
Language: not relevant
Currently, no evidence-based reimbursement process for human genetic testing exists in Austria. The 2025 AIHTA human genetics project addressed an overview of clinical indications for human genetic testing, evidence-based reimbursement processes (with a focus on prioritisation), and conducted two pilot assessments. There is ongoing interest in supporting the development of such processes, especially in relation to establishing a test directory and an appropriate, evidence-based reimbursement pathway.